![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, September 20, 2010 12:28:06 PM
Early Detection for Alzheimer's, Chronic Fatigue Syndrome and Other Diseases: In Vitro Diagnostic Tests from Neuro-Biotech Corp.
Neuro-Biotech Corp. Common Stock (USOTC:MRES)
Intraday Stock Chart
Today : Monday 20 September 2010
Click Here for more Neuro-Biotech Corp. Common Stock Charts.
Neuro-Biotech Corporation (PINKSHEETS: MRES)(OTCQB: MRES) is a worldwide biotechnological enterprise involved in the unique international niche of clinical neuroscience diagnostic testing. Neuro-Biotech Corp. uses proprietary molecular nanotechnology IVDDs (in vitro diagnostic devices) for the quantitative measurement of blood parameters to evaluate the input and output of the brain through specific neuro-biomarkers. As a result of more than 20 years of R&D, Neuro-Biotech Corp.'s specific expertise in clinical neurosciences applied enzymology is dedicated to the understanding of the relationship between the neurotransmitter families within the brain and their various influences on the peripheral systems involving the Hypothalamo-Pituitary Adreno-Sympathetic (HPAS) Axis. The HPAS Axis manages body mechanisms against stressful situations in order to maintain the homeostasis responsible for the resistance of the organism to its psycho-socio-environment through psycho-neuro-immune and endocrine systems.
This unique understanding of the communication between the brain and the human body, has led to the development of in vitro diagnostic blood tests. They are used for the detection, prevention, monitoring and follow-up of the major stress-related, socio-professional and occupational diseases, such as Chronic Fatigue Syndrome (CFS), Great Anxiety (GA), Panic Syndrome (PS), Neuropathies or Fibromyalgia (FM), Cardiovascular diseases like Essential Hypertension or Arrhythmia, Neurodegenerative diseases such as Alzheimer and Parkinson Diseases as well as Mental-Health Disorders in the vein of Depression and Schizophrenia.
Neuro-Biotech Corp's goals have resulted in a new and reliable portfolio of quantitative blood tests that provide general practitioners and specialists useful clinical parameters for the diagnosis of neuroscience-related diseases or physio-pathological impairments. This is accomplished by identifying abnormal readings of specific bio-markers within the blood or other biological fluids. Neuro-Biotech Corp's diagnostic tests are without equal in being non-invasive, sensitive, reliable and rapidly done as an essential complement to current clinical laboratory
testing procedures.
Neuro-Biotech presently has the opportunity to commercialize 12 clinical Neuro Blood Tests through partnerships, as specialized blood testing for a progressive clinical neuroscience investigation of targeted diseases, thus selectively monitoring specific neuro-biomarkers related to the neuro-immune and endocrine systems. Caregivers will now be able to evaluate and establish an individual's ability to react to stress and, to identify the appropriate neuro-endocrine and immune dysfunctioning. By monitoring bio-indicators related to workplace stress-related diseases and mental-health disorders, efficient patient treatment and follow-up are feasible.
Clinical Neuroscience-related diseases can be difficult to diagnose
and complex to treat.
If we don't know at what point an individual gets sick...and... at
what point he's better...
How can we manage the care and rehabilitation ?
Neuro-Biotech Corp. has the answer... that is...
EARLY DETECTION, MONITORING & APPROPRIATE FOLLOW-UP
Recent MRES News
- M2Bio Sciences Appoints Adrian J. Maizey, Accomplished CEO and Financial Expert, to Advisory Board • InvestorsHub NewsWire • 07/19/2023 01:18:56 PM
- M2Bio Sciences Unveils an Exciting Line of Purple, White, and Green Teas from Kenya, Offering Extraordinary Health and Medicinal Benefits • InvestorsHub NewsWire • 07/14/2023 12:52:00 PM
- M2Bio Sciences Unveils Explainer Video Showcasing Groundbreaking NFTs and Altcoins for Drug Discovery, Revolutionizing Investment Access • InvestorsHub NewsWire • 07/06/2023 01:38:23 PM
- Institute of Biomedical Research Announces Application for Name Change and New Ticker Symbol in Anticipation of Future M&A Activities and Senior Listing • InvestorsHub NewsWire • 07/05/2023 02:04:17 PM
- M2Bio Sciences Enters into Letter of Intent to Acquire Crypto Exchange JDAX • InvestorsHub NewsWire • 06/26/2023 12:45:19 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM